Pharmacokinetics and efficacy of tank water-administered BRAF-inhibitor dabrafenib in a zebrafish melanoma model 

Jenna Villman et al.

Dis Model Mech. 2026 Sep 14:dmm.052907. doi: 10.1242/dmm.052907. Online ahead of print.

Published on September 14, 2026

Abstract

ABSTRACT

Zebrafish models are widely used to study BRAF-mutant melanoma biology. However, long-term treatment of adult fish with small molecule BRAF inhibitors remains challenging, and pharmacokinetic data to inform rational dosing strategies are largely lacking for most small molecules in zebrafish. Here, we assessed the pharmacokinetics, metabolism, and efficacy of continuously tank water-administered BRAF inhibitor dabrafenib in adult zebrafish. Dabrafenib was rapidly absorbed from tank water, reaching efficacious plasma levels within one hour, but also showed fast elimination kinetics with a half-life of 1.0 hours. Most human metabolites of dabrafenib were detected in zebrafish, suggesting conserved metabolic processes. Continuous tank water administration achieved therapeutically relevant steady-state dabrafenib plasma levels that inhibited BRAF-driven signaling and produced robust efficacy in vivo in a genetic zebrafish model of BRAF-mutant melanoma without apparent toxicity. Together, these results demonstrate that continuous tank water administration of dabrafenib is a feasible, efficient, and well-tolerated dosing strategy in zebrafish melanoma models, and may facilitate dosing of other small molecule inhibitors, especially those with a short in vivo half-life in zebrafish.

PMID:42733341 | DOI:10.1242/dmm.052907

 Read More

← Back to Publications
Mikkola Lea et al.Biochem Biophys Rep. 2026 Nov 9;48:102875. doi: 10.1016/j.bbrep.2026.102875. eCollection 2026 Dec.
Gautier Follain et al.Bio Protoc. 2026 Nov 5;16(21):e5861. doi: 10.21769/BioProtoc.5861. eCollection 2026 Nov 5.
Francesca Bottanelli et al.J Cell Sci. 2026 Nov 1;139(21):jcs265433. doi: 10.1242/jcs.265433. Epub 2026 Nov 12.
Aliaa E Ali et al.Hum Mutat. 2026 Nov 8;2026:8234670. doi: 10.1155/humu/8234670. eCollection 2026.
Marie Christine Goess et al.J Crohns Colitis. 2026 Nov 7;20(11):jjag182. doi: 10.1093/ecco-jcc/jjag182.